{
  "trial_id": "NCT01552408",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, type of diabetes (Type 1 or Type 2), baseline BCVA score, baseline central retinal thickness, duration of diabetes, use of insulin, use of oral antihyperglycemic agents, history of prior ocular treatments, presence of concurrent ocular conditions, blood pressure, history of atrial fibrillation, history of stroke, presence of active systemic infection, presence of active malignancy, history of allergy to fluorescein.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex/Gender",
          "sex"
        ],
        [
          "Early Treatment Diabetic Retinopathy Study Best-Corrected Visual Acuity",
          "baseline BCVA score"
        ],
        [
          "Central Retinal Thickness",
          "baseline central retinal thickness"
        ],
        [
          "Diabetes Mellitus Diagnosis Year",
          "duration of diabetes"
        ]
      ],
      "remaining_reference_features": [
        "Race and Ethnicity Not Collected",
        "Number of Right Eyes Enrolled",
        "Glycated Hemoglobin",
        "Diabetic Macular Edema Diagnosis Year"
      ],
      "remaining_candidate_features": [
        "type of diabetes (Type 1 or Type 2)",
        "use of insulin",
        "use of oral antihyperglycemic agents",
        "history of prior ocular treatments",
        "presence of concurrent ocular conditions",
        "blood pressure",
        "history of atrial fibrillation",
        "history of stroke",
        "presence of active systemic infection",
        "presence of active malignancy",
        "history of allergy to fluorescein."
      ]
    },
    "processed-gen-response": "Age, sex, type of diabetes (Type 1 or Type 2), baseline BCVA score, baseline central retinal thickness, duration of diabetes, use of insulin, use of oral antihyperglycemic agents, history of prior ocular treatments, presence of concurrent ocular conditions, blood pressure, history of atrial fibrillation, history of stroke, presence of active systemic infection, presence of active malignancy, history of allergy to fluorescein."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Type of Diabetes, Baseline BCVA, Central Retinal Thickness, Duration of Diabetes, HbA1c, Blood Pressure, Prior Ocular Treatment,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex/Gender",
          "Sex: Female"
        ],
        [
          "Early Treatment Diabetic Retinopathy Study Best-Corrected Visual Acuity",
          "Baseline BCVA"
        ],
        [
          "Central Retinal Thickness",
          "Central Retinal Thickness"
        ],
        [
          "Glycated Hemoglobin",
          "HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Race and Ethnicity Not Collected",
        "Number of Right Eyes Enrolled",
        "Diabetes Mellitus Diagnosis Year",
        "Diabetic Macular Edema Diagnosis Year"
      ],
      "remaining_candidate_features": [
        "Male",
        "Race/Ethnicity",
        "Region of Enrollment",
        "Type of Diabetes",
        "Duration of Diabetes",
        "Blood Pressure",
        "Prior Ocular Treatment"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Type of Diabetes, Baseline BCVA, Central Retinal Thickness, Duration of Diabetes, HbA1c, Blood Pressure, Prior Ocular Treatment"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Diabetes Type, Diabetes Duration, BMI, Systolic Blood Pressure, Diastolic Blood Pressure, HbA1c, BCVA Score, Central Retinal Thickness Measurement, Presence of Vitreous Hemorrhage, Presence of Macular Hole, Presence of Rhegmatogenous Retinal Detachment.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex/Gender",
          "Sex: Female"
        ],
        [
          "Glycated Hemoglobin",
          "HbA1c"
        ],
        [
          "Early Treatment Diabetic Retinopathy Study Best-Corrected Visual Acuity",
          "BCVA Score"
        ],
        [
          "Central Retinal Thickness",
          "Central Retinal Thickness Measurement"
        ]
      ],
      "remaining_reference_features": [
        "Race and Ethnicity Not Collected",
        "Number of Right Eyes Enrolled",
        "Diabetes Mellitus Diagnosis Year",
        "Diabetic Macular Edema Diagnosis Year"
      ],
      "remaining_candidate_features": [
        "Male",
        "Diabetes Type",
        "Diabetes Duration",
        "BMI",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Presence of Vitreous Hemorrhage",
        "Presence of Macular Hole",
        "Presence of Rhegmatogenous Retinal Detachment"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Diabetes Type, Diabetes Duration, BMI, Systolic Blood Pressure, Diastolic Blood Pressure, HbA1c, BCVA Score, Central Retinal Thickness Measurement, Presence of Vitreous Hemorrhage, Presence of Macular Hole, Presence of Rhegmatogenous Retinal Detachment."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, diabetes type (1 or 2), duration of diabetes, current use of insulin or oral antihyperglycemic agents, BCVA score, central retinal thickness measurement, spherical equivalent of refractive error, blood pressure, history of vitrectomy surgery, history of pan-retinal photocoagulation, history of intraocular or subconjunctival steroids, history of antiangiogenic drugs, history of systemic corticosteroids, presence of concurrent ocular conditions, presence of concurrent systemic conditions.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex/Gender",
          "sex"
        ],
        [
          "Diabetes Mellitus Diagnosis Year",
          "duration of diabetes"
        ],
        [
          "Early Treatment Diabetic Retinopathy Study Best-Corrected Visual Acuity",
          "BCVA score"
        ],
        [
          "Central Retinal Thickness",
          "central retinal thickness measurement"
        ]
      ],
      "remaining_reference_features": [
        "Race and Ethnicity Not Collected",
        "Number of Right Eyes Enrolled",
        "Glycated Hemoglobin",
        "Diabetic Macular Edema Diagnosis Year"
      ],
      "remaining_candidate_features": [
        "diabetes type (1 or 2)",
        "current use of insulin or oral antihyperglycemic agents",
        "spherical equivalent of refractive error",
        "blood pressure",
        "history of vitrectomy surgery",
        "history of pan-retinal photocoagulation",
        "history of intraocular or subconjunctival steroids",
        "history of antiangiogenic drugs",
        "history of systemic corticosteroids",
        "presence of concurrent ocular conditions",
        "presence of concurrent systemic conditions."
      ]
    },
    "processed-gen-response": "Age, sex, diabetes type (1 or 2), duration of diabetes, current use of insulin or oral antihyperglycemic agents, BCVA score, central retinal thickness measurement, spherical equivalent of refractive error, blood pressure, history of vitrectomy surgery, history of pan-retinal photocoagulation, history of intraocular or subconjunctival steroids, history of antiangiogenic drugs, history of systemic corticosteroids, presence of concurrent ocular conditions, presence of concurrent systemic conditions."
  }
}